A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

No Carolina / New York

GE HealthCare Announces Availability of Next-Generation bkActiv for Guiding Urology, Colorectal and Pelvic Floor Surgeries

GE HealthCare (Nasdaq: GEHC) announced today the next-generation bkActiv is now available for guiding urology, colorectal and pelvic floor surgical procedures. The flagship intraoperative ultrasound imaging system, developed by BK Medical – a subsidiary of GE HealthCare, was designed to deliver high-performance ultrasound guidance with a simplified, intuitive user experience for surgeons. The bkActiv’s automatic no-touch autogain and advanced algorithms provide unmatched image quality, enabling confident decision making during surgical procedures. The system allows for minimal user interaction so that surgeons can focus on their patients.

“By expanding the bkActiv system, we are giving physicians the tools they need to provide precise treatment with the ability to see fine details in image guidance, which ultimately may allow for better outcomes for people who require urology, colorectal and pelvic floor procedures,” said Urvi Vyas, General Manager, Surgical Visualization & Guidance, Ultrasound at GE HealthCare, “We are proud to be the trusted partner for surgeons around the world given our long history of leadership in imaging and innovation.”

The bkActiv is a high-performance imaging system that allows for detailed, real-time surgical visualization, refined through decades of research, real-world use, and extensive user feedback. With this addition, the bkActiv now supports next level image quality of the prostate, kidney, and bladder, and has sensitive color doppler to visualize and measure the speed and direction of blood flow during the most complex surgical procedures. Combined with the new advanced portfolio of specialized, sterilizable transducers, needle guides, and procedure packs, the solution is designed to assist surgeons from simple procedures, such as biopsies, to the most advanced robotic surgeries.

The system’s features are designed with the physician in mind, and include:

  • Intuitive design with True-Sense touch technology and Smart Button that allow surgeons to operate the system with one hand for full control during the procedure
  • Advanced transducer portfolio including robotic and laparoscopic transducers
  • Adjustable monitor mounted on a flexible arm that allows for optimal image viewing with landscape or portrait mode
  • Easy integration into a crowded operating room due to its minimal system footprint

With the acquisition of BK Medical in 2021, GE HealthCare adds the fast-growing field of real-time surgical visualization to its pre- and post-operative ultrasound capabilities, creating an end-to-end offering through the full continuum of care. GE HealthCare has a long history of ultrasound innovation and a successful track record of growing technology acquisitions.

For more information on the bkActiv system for Urology visit: https://www.bkmedical.com/systems/bkactiv-urology/

For more information on the bkActiv system for Colorectal Surgery visit: https://www.bkmedical.com/systems/bkactiv-colorectal-surgery/

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Dr. Sachita Shah, Sr. Director, Global Health, Butterfly Network, "Butterfly is proud to continue improving maternal health equity through Phase Two of the largest-scale handheld ultrasound distribution and training ever conducted in Sub-Saharan Africa. South Africa is an emerging market that continues to have disproportionately high rates of maternal mortality and stillbirth. Patients need easier access to antenatal imaging, and clinicians need better capabilities for screening high-risk conditions that lead to disproportionately worse pregnancy outcomes in rural areas in the public sector. Together with CHAI and GUSI, we can tackle this by making ultrasound much more accessible, so high-risk conditions can be identified earlier in care, which is known to improve outcomes.”
The clinical Study will enroll up to 97 patients at up to 12 European investigational sites. Completion of the study is expected this year, and results will support CE mark and pre-market approval submissions reports Vivasure Medical.
Dr. Michael Newman, Indaptus’ Founder, Chief Scientific Officer, and lead author, commented, “The new data are consistent with our preclinical animal tumor model studies and provide evidence for our hypothesis that patented Decoy bacteria can activate a wide range of innate and adaptive human immune cells involved in fighting tumors.  This aligns with what we’ve observed in our ongoing Phase 1 clinical trial of Decoy20 – broad immune activation, as evidenced by transiently increased levels of many key cytokines and chemokines following single dose administration. These findings bolster our confidence in Decoy20's potential as a multifaceted immunotherapy.”
To further understand the impact of platforms like TikTok on nutrition trends, MyFitnessPal partnered with Dublin City University on a research and experimental study that examined diet and nutrition content on TikTok. The study analyzed over 67,000 videos using Artificial Intelligence to compare them against public health and nutrition guidelines
Leveraging the power of Apple Vision Pro to seamlessly blend digital content with the physical world Osso Health brings the operating experience to life via detailed, clinically accurate workflows of common procedures.

By using this website you agree to accept Medical Device News Magazine Privacy Policy